G20.1
Conditions
Interventions
Group 1: intervention: Usage of the “Parkinson Go TM” digital care system in addition to standard therapy for Parkinson's patients (standard therapy = recent medication plan and
on-site physiotherapy
Sponsors
Portabiles Healthcare Technologies GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Parkinson's disease, clinically confirmed diagnosis by neurology specialist • Duration of disease = 2 years • MDS-UPDRS III = 13 points in the medicated ON state • Need for optimization, especially gait instability/bradykinesia present • Inclusion possible in case of fluctuations in effect (UPDRS IV = 50% of the day) • Routine smartphone usage in everyday life • Free walking possible for at least 4 x 10m • Sufficient motivation on the part of the patient to use medication/physiotherapy/app/teletherapy
Exclusion criteria
Exclusion criteria: • Initial medication • (Leading) alternative causes of gait/balance disorder (PNP, spinal stenosis, post-stroke spasticity, post-stroke paralysis, vestibular disorder, ataxia, acute musculoskeletal disorders) • Severe visual/reading impairment, hypacusis (teleconsultation) • MMST = 26 points • Lack of affinity for technology, excessive demands with smartphones/smart technologies in everyday life • Planned hospital stays/vacations during the first 2 weeks of app use (mandatory) • Planned hospital stays/vacations Study duration (exception: sensors can be worn as planned and video exercises can be continued consistently) • Serious side effects (hallucinations, impulse control disorder, sleep attacks) that require an acute adjustment of medication • Participation in another intervention study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health status/mobility is assessed using the standardized motor section of the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS III) at the time of the inclusion visit and after 3 months at the exclusion visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Gait quality (Functional Gait Assessment Score = FGA-Score, Activity Balance Confidence Scale = ABC-Scale), quality of life (Parkinson's Disease Questionnaire = PDQ-39), usability tele-service (System Usability Scale = SUS), health economic evaluation (own questionnaire, survey of outpatient-sensitive cases of illness and care-sensitive cases of illness) | — |
Countries
France, Germany, Spain
Contacts
Public ContactSabine Stallforth
Abteilung für Molekulare Neurologie Universitätsklinik Erlangen
Outcome results
None listed